Plasma-First to Accelerate Time to Treatment and Improve Target Detection in Advanced Lung Cancer: A Prospective Study
Journal of Thoracic Oncology(2023)
Abstract
Liquid biopsy is emerging as a complement to tumor tissue profiling in advanced non-small-cell lung cancer (NSCLC) patients. We prospectively evaluated the use of a plasma-first approach in the initial diagnostic work-up of patients with suspected advanced NSCLC (NCT04862924).
MoreTranslated text
Key words
NSCLC,liquid biopsy,plasma-first
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined